Entrada Therapeutics, Inc. (TRDA)

Typically moves ±8.20% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Entrada Therapeutics, Inc. (TRDA) has a 19-report earnings history dating back to Dec 09, 2021. Its average absolute post-earnings move is ±8.20%, and 68.4% of those reactions were positive. Its largest post-earnings gain was +11.26% (Aug 13, 2024) and its largest decline was -57.04% (May 07, 2026). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How TRDA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.20%

Positive %

68.4%

Negative %

31.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☀ PRE	-2.34%	open_in_new
May 07, 2026	☀ PRE	-57.04%	open_in_new
Feb 26, 2026	☀ PRE	+6.76%	open_in_new
Nov 06, 2025	☀ PRE	+0.14%	open_in_new
Aug 06, 2025	☀ PRE	+2.06%	open_in_new
May 08, 2025	☀ PRE	+5.64%	open_in_new
Feb 27, 2025	☀ PRE	-0.33%	open_in_new
Nov 05, 2024	☀ PRE	+4.78%	open_in_new
Aug 13, 2024	☀ PRE	+11.26%	open_in_new
May 07, 2024	☀ PRE	+2.81%	open_in_new
Mar 13, 2024	☀ PRE	+9.76%	open_in_new
Nov 07, 2023	☀ PRE	+8.63%	open_in_new
Aug 08, 2023	☀ PRE	+10.47%	open_in_new
May 10, 2023	☀ PRE	-2.13%	open_in_new
Mar 06, 2023	☀ PRE	-1.41%	open_in_new
Nov 07, 2022	☀ PRE	-10.02%	open_in_new
May 12, 2022	☀ PRE	+10.25%	open_in_new
Mar 15, 2022	☀ PRE	+9.78%	open_in_new
Dec 09, 2021	☀ PRE	+0.14%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.20%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →

Funds holding

$47725021

Total value held

Buying

17 added · 3 reduced

Blackrock, Inc.

$19013332 +9.52%

Merck & Co., Inc.

$12804692 NEW BUY

State Street Corp

$4391543 +11.78%

Jpmorgan Chase & Co

$3827683 +3243.82%

Northern Trust Corp

$2281173 +31.89%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260909	open_in_new SEC.gov
4	20260909	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260831	open_in_new SEC.gov
4	20260831	open_in_new SEC.gov

Frequently asked about TRDA earnings

When does Entrada Therapeutics, Inc. report earnings next? expand_more

Entrada Therapeutics, Inc. (TRDA)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TRDA stock move after earnings? expand_more

Over 19 reports, TRDA has moved an average of ±8.20% the session after earnings, closing higher 68.4% of the time.

What was TRDA's biggest post-earnings move? expand_more

TRDA's largest post-earnings gain on record was +11.26% on Aug 13, 2024, and its largest decline was -57.04% on May 07, 2026.

Where can I find Entrada Therapeutics, Inc.'s SEC filings? expand_more

All of Entrada Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.